Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (251-260 of 643) with videos related to

Pageof 65
Sort By:
Pathology, Research and Practice|November 17, 2022
Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasiaFilippo Cappello, Valentina Angerilli, Luca Dal Santo, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
BMC Cancer|August 21, 2019
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancerLisa Perilli, Sofia Tessarollo, Laura Albertoni, et al.
Cancer Medicine|October 25, 2022
Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal statusAndromachi Kotsafti, Matteo Fassan, Francesco Cavallin, et al.
Histopathology|August 14, 2012
Early HER2 dysregulation in gastric and oesophageal carcinogenesisMatteo Fassan, Luca Mastracci, Federica Grillo, et al.
Frontiers in Oncology|April 12, 2021
<i>PIK3CA</i> Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerNicola Fusco, Umberto Malapelle, Matteo Fassan, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2023
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reportingFederica Grillo, Valentina Angerilli, Paola Parente, et al.
International Journal of Molecular Sciences|November 4, 2020
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic StrategiesGiovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, et al.
Oncotarget|November 1, 2014
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesisCarmine Carbone, Geny Piro, Matteo Fassan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2020
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialGiuseppe Pasqualetti, Marta Schirripa, Emmanuelle Dochy, et al.
Pageof 65

Showing results (251-260 of 643) with videos related to

Sort By:
Pageof 65
Pathology, Research and Practice|November 17, 2022
Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasiaFilippo Cappello, Valentina Angerilli, Luca Dal Santo, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
BMC Cancer|August 21, 2019
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancerLisa Perilli, Sofia Tessarollo, Laura Albertoni, et al.
Cancer Medicine|October 25, 2022
Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal statusAndromachi Kotsafti, Matteo Fassan, Francesco Cavallin, et al.
Histopathology|August 14, 2012
Early HER2 dysregulation in gastric and oesophageal carcinogenesisMatteo Fassan, Luca Mastracci, Federica Grillo, et al.
Frontiers in Oncology|April 12, 2021
<i>PIK3CA</i> Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerNicola Fusco, Umberto Malapelle, Matteo Fassan, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2023
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reportingFederica Grillo, Valentina Angerilli, Paola Parente, et al.
International Journal of Molecular Sciences|November 4, 2020
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic StrategiesGiovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, et al.
Oncotarget|November 1, 2014
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesisCarmine Carbone, Geny Piro, Matteo Fassan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2020
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialGiuseppe Pasqualetti, Marta Schirripa, Emmanuelle Dochy, et al.
Pageof 65